Table 2.
Comparison of characteristics between BU+HIV+ patients and BU+HIV− patients (age-matched controls)
| Characteristic | ||
|---|---|---|
| BU+HIV+ Patients (n = 9) | BU+HIV− (n = 7) |
|
| Age, median years (Range) | 42 (18–50) | 40 (24–51) |
| Gender, male, n (%) | 4 (44.4) | 2 (28.6) |
| Gender, female, n (%) | 5 (55.6) | 5 (71.4) |
| Weight, median Kg (IQR) | 50 (44, 59) | 58 (50, 65) |
| Duration before seeking treatment, median weeks (IQR) | 8 (4,26) | 4 (2,10) |
| Clinical Forms n (%) | ||
| Ulcer | 8(88.9) | 7 (100) |
| Nodule | 1(11.1) | |
| WHO Categories, n (%) | ||
| I (<=5 cm) | 3 (33.3) | 2 (28.6) |
| II (5-15 cm) | 5 (55.6) | 5 (71.4) |
| III (> 15 cm) | 1 (11.1) | |
| Location of the lesion, n (%) | ||
| Lower limb (LL) | 6(66.7) | 5 (71.4) |
| Upper limb (UL) | 2 (22.2) | 1 (14.3) |
| Other locations | 1 (11.1) | 1 (14.3) |
| Treatment type, n (%) | ||
| SR8 | 7 (77.8) | 5 (71.4) |
| CR8 | 2 (22.2) | 2 (28.6) |
| IS2404, median cps/ml (IQR) | 500 (500, 500) | 500 (500,10,000) |
| M. ulcerans 16SrRNA, median cps/ml (IQR) | 750 (125,83,050) | 500 (0, 32,500) |
| Healing, median weeks (IQR) | 14(8,28) | 28(12,33) |